6ehv: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery== | ==scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery== | ||
<StructureSection load='6ehv' size='340' side='right' caption='[[6ehv]], [[Resolution|resolution]] 2.54Å' scene=''> | <StructureSection load='6ehv' size='340' side='right'caption='[[6ehv]], [[Resolution|resolution]] 2.54Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[6ehv]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6EHV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6EHV FirstGlance]. <br> | <table><tr><td colspan='2'>[[6ehv]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6EHV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6EHV FirstGlance]. <br> | ||
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ehv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ehv OCA], [http://pdbe.org/6ehv PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ehv RCSB], [http://www.ebi.ac.uk/pdbsum/6ehv PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ehv ProSAT]</span></td></tr> | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ehv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ehv OCA], [http://pdbe.org/6ehv PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ehv RCSB], [http://www.ebi.ac.uk/pdbsum/6ehv PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ehv ProSAT]</span></td></tr> | ||
</table> | </table> | ||
==See Also== | |||
*[[Antibody 3D structures|Antibody 3D structures]] | |||
*[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]] | |||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | |||
[[Category: Large Structures]] | |||
[[Category: Hargreaves, D]] | [[Category: Hargreaves, D]] | ||
[[Category: Abvance]] | [[Category: Abvance]] | ||
Latest revision as of 07:06, 16 October 2019
scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery
| ||||||||||||
